ICPT
Intercept Pharmaceuticals, Inc.
ICPT
ICPT
Delisted
ICPT was delisted on the 7th of November, 2023.
167 hedge funds and large institutions have $2.5B invested in Intercept Pharmaceuticals, Inc. in 2017 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 63 increasing their positions, 52 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
167
Holders Change
+17
Holders Change %
+11.33%
% of All Funds
4.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
28
Increased
63
Reduced
52
Closed
11
Calls
$112M
Puts
$65.7M
Net Calls
+$46.5M
Net Calls Change
+$21.5M
Top Buyers
| 1 |
Millennium Management
New York
|
$23M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
$13.8M |
| 3 |
AC
Ascend Capital
Orinda,
California
|
$9.83M |
| 4 |
CWAM
Columbia Wanger Asset Management
Chicago,
Illinois
|
$8.94M |
| 5 |
BlackRock
New York
|
$138M |
Top Sellers
| 1 |
JPMorgan Chase & Co
New York
|
$61M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
$312M |
| 3 |
O
OrbiMed
New York
|
$104M |
| 4 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
$2.02M |
| 5 |
Norges Bank
Oslo,
Norway
|
$673K |